No Disease or Condition is Being Studied
13
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (13)
The Effect of a Nap Protocol on the Cognitive Abilities of Experienced Teachers
Effects of an 8-week Plyometric Training Programme on Sprint, Jump, and Agility Performance in Recreational Male Football Players Aged 14-16 Years
Hand Versus Foot Controls for Robotic Surgery Simulation
Acute Psychological and Physiological Effects of Cannabigerol
Caring for Dementia Caregivers in Ethnic Immigrant Communities
Optimizing Operational Parameters for Diagnostic Vitrectomy
Evaluation of the Performance and Safety of VACUSERA® PRP Tubes in the Preparation of Autologous Platelet-Rich Plasma
Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)
ANI-Guided Fentanyl Infusion During Living Donor Liver Resections
Ergonomic Protocol for Competitive E-Sport Athletes
The Effects of Gyngerlean Supplementation on Energy Expenditure
Supporting Secondary School Student Wellbeing Through a Mobile App and Wearable Biofeedback
Evaluation of Virtual Reality in Hazmat Training